Managing Insulin Resistance in HIV-Infected Patients

Now Available!

CME-Certified Interactive Case Challenge:

CME-Certified Module:

Downloadable Slideset:

Managing Dyslipidemia in HIV-Infected Patients on Therapy: Switch Antiretrovirals or Add Lipid-Lowering Agents?

Now Available!

Downloadable Audio and Slideset:

Managing Dyslipidemia in HIV-Infected Patients on Therapy Marshall J. Glesby, MD, PhD, and James H. Stein, MD, review evidence for managing HIV-infected patients with dyslipidemia—should one switch antiretroviral therapy or add lipid-lowering agents? Downloadable Audio and Slideset

Coming Soon!

CME-Certified Module:

Managing Dyslipidemia in HIV-Infected Patients on Therapy: Switch Antiretrovirals or Add Lipid-Lowering Agents? Marshall J. Glesby, MD, PhD, and James H. Stein, MD, review evidence, discuss cases, and answer questions on the strategy of switching antiretroviral therapy vs adding lipid-lowering drugs for managing HIV-infected patients with dyslipidemia.

2008 International AIDS Conference

CCO's official coverage of the 2008 International AIDS Conference includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio and video Expert Highlights that focus on key issues highlighted at the conference.

• Timing and Choice of First-Line Antiretroviral Therapy

Joel E. Gallant, MD, MPH; José Gatell, MD; and W. David Hardy, MD

• Management of Treatment-Experienced Patients

Joseph J. Eron, Jr., MD; Kimberly Y. Smith, MD, MPH; and Andrew R. Zolopa, MD 

• Clinical Complications of HIV and Its Therapy

Andrew Carr, MBBS, MD, FRACP, FRCP; Donald P. Kotler, MD; and Bruce Polsky, MD

• HIV Management in Women

Judith S. Currier, MD, MSc; Sally Hodder, MD; and Kathleen E. Squires, MD

• Treatment and Biomedical Prevention in Resource-Limited Settings

Richard E. Chaisson, MD; Elly Katabira, MD; and Mauro Schechter, MD, PhD

New Insights Into the Use of PIs Across the Treatment Spectrum

Now Available!

CME-Certified Video Module:

Downloadable video segments and transcripts:

• Recent Advances in PI Therapy
• Selecting an Antiretroviral Regimen for a Woman Recently Diagnosed With HIV
• Making Treatment Decisions for a Chronically Ill Patient With Virologic Failure of an Initial PI-Based Regimen
• Management of an HIV-Infected Female With Dyslipidemia on a PI-Based Regimen
• Management of an Antiretroviral-Experienced Patient With Low-Level Viremia and Availability of Multiple PIs With Suspected Activity
• Treatment Considerations for a Highly Treatment-Experienced Patient With No Fully Active PIs

CCO Slideset:

Novel Agents for Treatment-Experienced Patients: Faculty Mentoring for Managing Challenging Cases

Now Available!

CME-Certified Video Module:

Downloadable Transcripts:

• Case 1: Highly Experienced Patient With Virologic Rebound on Many Successive Regimens
  Join Kimberly Y. Smith, MD, MPH; Sally Hodder, MD; and Andrew R. Zolopa, MD, as they guide you through the decision-making process for the construction of a new regimen for this highly treatment–experienced patient.

• Case 2: Highly Experienced Patient Who Has Never Achieved Virologic Suppression
  Kimberly Y. Smith, MD, MPH; Sally Hodder, MD; and Andrew R. Zolopa, MD, discuss the pearls and pitfalls of planning therapy for this highly treatment–experienced patient.

Integrating New Antiretroviral Agents Into Therapeutic Strategies for Treatment-Experienced Patients

Newly Available!

CCO HIV Stay Tuned

Bimonthly CME-certified audio Podcasts, each supported by a variety of online resources.

Evolving Concepts in Antiretroviral Therapy—Volume 1, Edition 3 Watch and listen to CCO's expert faculty discuss evolving concepts in antiretroviral therapy. Then download audio, video, and slides for additional reference and use in your own talks. Click here to start.

Also Available!

• Evolving Concepts in Antiretroviral Therapy—Volume 1, Edition 1
• Evolving Concepts in Antiretroviral Therapy—Volume 1, Edition 2

HIV/AIDS Annual Update 2008

Clinical Care Options' HIV/AIDS Annual Update offers the latest information across a wide range of issues for the optimal clinical management of your patients. Expert faculty members prepared the following CME-certified educational modules that are now available on the CCO Web site:

CME-Certified Modules:

• HIV Disease Pathogenesis and the Gastrointestinal Tract
• Eradication of HIV: Possible or Still a Pipe Dream?
• New Findings on Resistance to NRTIs, NNRTIs, and PIs
• Novel Antiretroviral Agents
• Clinical Strategies for Initiation of Antiretroviral Therapy
• Non−AIDS-Defining Cancers in the Era of HAART
• Neurologic Aspects of HIV Infection and Its Therapy
• Advances in HIV/HCV Coinfection
• The US HIV Epidemic: Why Is Prevention Failing?
• The Global HIV Epidemic: Updates on Epidemiology and Prevention
  

The Role of Integrase Inhibitors in HIV Management

2 CME-Certified Modules by Martin Markowitz, MD:

• Targeting Integrase: Mechanisms of Action and Mechanisms of Resistance to Integrase Inhibitors
  Martin Markowitz, MD, discusses the role of the integrase enzyme in the HIV replication cycle and the development of resistance to integrase inhibitors.
  
• Clinical Studies of Integrase Inhibitors: A Comprehensive Review
  Martin Markowitz, MD, discusses recent data from clinical studies involving the use of the integrase inhibitors raltegravir and elvitegravir.

CME-Certified Module by David A. Cooper, MD, DSc:

• From Bench to Bedside: The Clinical Role of Integrase Inhibitors
  David A. Cooper, MD, DSc, discusses clinical data on the use of integrase inhibitors for the management of treatment-experienced and treatment-naive HIV-infected patients.

Interactive Case Challenges:

• Management of a Moderately Treatment-Experienced Male Using Novel Antiretroviral Agents
  Andrew R. Zolopa, MD, discusses key issues in the management of a chronically infected patient with persistent viremia.
  
• Management of a Virologically Suppressed Patient Experiencing Injection-Site Reactions With His Current Regimen
  Jonathan M. Schapiro, MD, discusses management issues in the case of a treatment-experienced male who is experiencing intolerable adverse effects from his successful regimen.
  
• Management of a Patient With Extensive Antiretroviral Experience and Persistent Low-Level Viremia
  Edwin DeJesus, MD, FACP, discusses issues in managing a clinically stable male patient who has not been able to achieve undetectable HIV-1 RNA.

CCO Slideset:

• The Role of Integrase Inhibitors in HIV Management
  Martin Markowitz, MD, presents findings on the function of integrase and the role of integrase inhibitors in the management of HIV disease.

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy

Now Available!

CME-certified Virtual Presentation:

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy Paul E. Sax, MD, discusses the latest data regarding when to start antiretroviral therapy.

CME-certified Slideset:

Evolving Insights Into the Optimal Timing of Antiretroviral Therapy Paul E. Sax, MD, reviews the optimal timing of antiretroviral therapy in response to revised recommendations issued by the Department of Health and Human Services.

CCO Independent Conference Coverage of the 2008 Conference on Retroviruses and Opportunistic Infections

CME-Certified Expert Analyses:

• First-Line Therapy and Switch Strategies
• Management of Treatment-Experienced Patients
• Antiretroviral Drug Resistance
• Metabolic Complications and Adverse Events
• Hepatitis and Opportunistic Coinfections
  

CME-Certified Expert Recaps:

• First-Line Therapy and Switch Strategies
• Management of Treatment-Experienced Patients

And downloadable PowerPoint slides for review or to use in your own talks!

Answering the Questions: Practical Management Strategies to Address Cardiovascular Risk in HIV

CME-Certified Modules:

CCO Slideset:

Answering the Questions: Practical Management Strategies for Cardiovascular Risk in HIV Pablo Tebas, MD reviews key data on frequently asked questions about diagnosing and managing cardiovascular risks in HIV-infected patients.

HIV Journal Options - Volume 4, Issue 1

HIV Journal Options - Volume 4, Issue 2

HIV Journal Options - Volume 4, Issue 3 - Now Available!

New Topics include:

• Fibrosis Progression for HCV/HIV-Coinfected Patients
• Single-Agent PI Therapy
• HCV Superinfection
• Data Supporting an Earlier Start for Antiretrovirals
• Impact of HIV Suppression and Kidney Disease Stage on Renal Function
• Non-AIDS Cancers in an Aging HIV-Infected Population
• Benefits and Risks of HLA-B*5701 Screening for Abacavir Hypersensitivity
• Insights Into the Impact of Intermittent Viremia

From Theory to Practice: Strategies for the Successful Management of Treatment-Experienced Patients

Interesting Interactive Case Challenges and Commentaries that explore treatment decisions for antiretroviral-experienced patients.

Interactive Case Challenges - Wave 1:

• Management of a Moderately Treatment-Experienced HIV-Infected Patient With Virologic Failure: Anton L. Pozniak, MD, FRCP
• Management of a Highly Treatment-Experienced HIV-Infected Patient With Low-Level Viremia and a High CD4+ Cell Count: Edwin DeJesus, MD, FACP

Interactive Case Challenges - Wave 2:

• Management of a Patient With Virologic Failure of an Initial PI-Based Regimen: W. David Hardy, MD
• Optimizing Therapy for a Highly Treatment-Experienced Patient With Viremia Currently on a Nonsuppressive Regimen: Joseph J. Eron, Jr., MD

Expert Commentaries:

• Practical Strategies for Managing Treatment-Experienced Patients: An Overview of the Wave 1 Interactive Case Challenges
• Practical Strategies for Managing Treatment-Experienced Patients: An Overview of the Wave 2 Interactive Case Challenges

• 2008 Conference on Retroviruses and Opportunisitic Infections *
  
  
• 2007 European AIDS Conference*
  
  
• 2007 Interscience Conference on Antimicrobial Agents and Chemotherapy *
  
  
• 2007 IAS Conference on HIV Pathogenesis, Treatment and Prevention
  
  
• 2007 International HIV Drug Resistance Workshop*
  
  
  
  

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

• Rethinking the Role of NNRTIs: Clinical Strategies for Optimizing Outcomes With Next-Generation Agents
  Joseph J. Eron, Jr., MD, discusses clinical data and strategies important for optimal use of next-generation NNRTIs in the management of HIV-infected patients. Access case vignettes by Joseph J. Eron, Jr., MD, Pablo Tebas, MD, and W. David Hardy, MD.
  
  
• The Clinical Impact of Next-Generation NNRTIs: Recent Research and Practical Treatment Strategies
  A comprehensive review of data from clinical trials investigating first- and next-generation NNRTIs as well as a discussion regarding the clinical need for and potential impact of next-generation NNRTIs.
  
  
• Simple From the Start: The Importance of Treatment Convenience in Antiretroviral Therapy
  2 CME-certified modules by Edwin DeJesus, MD, FACP and 3 Interactive Case Chalenges
  
  
• Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection
  Access 2 CME-certified  modules and a downloadable slideset.
  
  
• Right From the Start: Optimizing First-Line Antiretroviral Therapy
  Read educational modules from, Kimberly Y. Smith, MD, MPH, Edwin DeJesus, MD, FACP, Paul E. Sax, MD, and Valerie E. Stone, MD, MPH.
  
  
• HIV Entry and Tropism: New Strategies for Effective Antiretroviral Therapy
  Review educational modules and then download slides for your talks.
  
  
• New Classes of Antiretrovirals: The Potential Clinical Role of Integrase Inhibitors and Entry Inhibitors
  CME-certified modules on these exciting new classes of drugs for treatment-experienced patients.

• Psychiatric Disorders in HIV-Infected Patients
  Review 2 educational modules and 3 case challenges.
  
  
• When to Start, What to Use: A Master Class in the Use of First-Line Antiretroviral Therapy
  Review 3 Modules, Interactive Case Challenges and an interactive tool.
  

• Selection of Initial Therapy for a 48-Year-Old HIV/TB-Coinfected Woman With CVD Risk Factors
  Anton L. Pozniak, MD, FRCP, discusses drug interaction and adherence issues in designing a therapy for a 48-year-old woman coinfected with HIV and tuberculosis.
  
  
• Management of a 38-Year-Old Male on Methadone Maintenance Therapy Who Presents With PCP
  William G. Powderly, MD, discusses the selection of initial therapy for a 38-year-old recovering injection drug user male with HIV/hepatitis C virus coinfection who presents with Pneumocystis jirovecii pneumonia (PCP).
  
  
• Management of a 38-Year-Old Otherwise Healthy Married Man Recently Diagnosed With HIV Infection
  Edwin DeJesus, MD, FACP, discusses key concerns about the initiation of antiretroviral therapy for a 38-year-old busy professional man recently diagnosed with HIV.
  
  
• Selection of an Initial Regimen for a Patient With a Family History of Cardiovascular Disease
  William G. Powderly, MD, challenges your knowledge of assessing cardiovascular risk for this patient as you select his initial regimen.
  
  
• Management of Dyslipidemia in an HIV-Infected Man With Grave Cardiac Risk
  Jens D. Lundgren, MD, DMSc, and Signe Westring Worm, MD, guide participants through the assessment of cardiac risk and treatment choices in a middle-aged patient with a high risk of a cardiovascular event.
  
  
  

Topics

• Adverse Effects and Comorbidities
• Antiretroviral Management
• Epidemiology and Natural History
• Opportunistic Diseases and Coinfection
• Pharmacology
• Resistance
• Special Populations

Resources

• Advanced Search
• Animations
• Case Challenges
• Free Bookstore
• Live Events
• Slide Download Library
• Interactive Tools

FEATURED VIDEO HIGHLIGHT
IAC Late Breaker Sessions From Mexico City

Daniel R. Kuritzkes, MD, highlights clinically relevant data from key studies presented at the 2008 International AIDS Conference Late Breaker Sessions. Click here to Start

Improved Survival Associated With HAART After TB Diagnosis

HAART, regardless of timing initiation, associated with lower risk of death and increased rate of completing TB treatment in HIV/TB-coinfected patients vs patients not receiving HAART

Click here for related Capsule Summaries.

Click here for more slides

Click here for the bookstore

Click here for more tools

Click here for more cases